Title: Joseph Wettstein: Innovator in Multiple Sclerosis Treatment Introduction Joseph Wettstein is a notable inventor based in Lebanon, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. With a total of 2 patents, his work focuses on innovative compounds that aim to alleviate the symptoms associated with this challenging condition. Latest Patents Wettstein's latest patents include two groundbreaking inventions. The first patent is titled "Use of thiazolobenzoheterocycles for treating multiple sclerosis." This invention relates to the use of a compound of Formula I in treating patients for inflammatory or neuropathic pain, as well as various symptoms of multiple sclerosis. The second patent is "Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis." This invention also focuses on the use of a compound of Formula I in treating patients for the symptoms of multiple sclerosis. Career Highlights Joseph Wettstein is currently associated with Aventis Pharmaceuticals Inc., where he continues to develop innovative solutions for medical challenges. His work has garnered attention in the pharmaceutical industry, contributing to advancements in treatment options for patients suffering from multiple sclerosis. Collaborations Wettstein has collaborated with notable colleagues, including Bin Zhu and Margaret Petty. These partnerships have played a crucial role in enhancing the research and development of his patented inventions. Conclusion Joseph Wettstein's contributions to the field of medicine, particularly in the treatment of multiple sclerosis, highlight his innovative spirit and dedication to improving patient care. His patents represent significant advancements in therapeutic options for those affected by this condition.

Growing community of inventors

Lebanon, NJ, United States of America

Joseph Wettstein